Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 2/20 | 0.64 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | EYA2 | O00167 | 1/20 | 0.59 |
| ▸ | APP | P05067 | 1/20 | 0.59 |
| ▸ | ACE | P12821 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | DRD1 | P21728 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6347011 | 0.95 | BLM (0.58) | BLMPMP22HSD17B10TDP1EYA2 | |
| SCHEMBL18412665 | 0.92 | BLM (0.55) | BLMPMP22HSD17B10TDP1EYA2 | |
| SCHEMBL10213863 | 0.87 | BLM (0.50) | BLMPMP22HSD17B10TDP1EYA2 | |
| SCHEMBL20672100 | 0.87 | BLM (0.80) | BLMPMP22HSD17B10TDP1EYA2 | |
| SCHEMBL14012821 | 0.87 | BLM (0.50) | BLMPMP22HSD17B10TDP1EYA2 | |
| SCHEMBL16390501 | 0.86 | TDP1 (0.54) | BLMPMP22HSD17B10TDP1EYA2 | |
| SCHEMBL4047027 | 0.86 | BLM (0.48) | BLMPMP22HSD17B10TDP1EYA2 | |
| SCHEMBL10170320 | 0.86 | BLM (0.48) | BLMPMP22HSD17B10TDP1EYA2 | |
| SCHEMBL20435737 | 0.85 | BLM (0.52) | BLMPMP22HSD17B10TDP1EYA2 | |
| SCHEMBL10283831 | 0.84 | BLM (0.47) | BLMPMP22HSD17B10TDP1EYA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150024123-A1 | CATALYSTS FOR ELECTROLESS METALLIZATION CONTAINING IMINODIACETIC ACID AND DERIVATIVES | ROHM AND HAAS ELECTRONIC MATERIALS LLC | 2015-01-22 | — | — | US | claimed |
| EP-2826562-A2 | Catalysts for electroless metallization containing iminodiacetic acid and derivatives | Rohm and Haas Electronic Materials LLC (US) | 2015-01-21 | — | — | EP | claimed |
| CN-104294240-A | Catalysts for electroless metallization containing iminodiacetic acid and derivatives | ROHM & HAAS ELECT MAT | 2015-01-21 | — | — | CN | claimed |
| US-8822390-B2 | Scale inhibitor | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-09-02 | — | — | US | claimed |
| EP-2155162-B1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB (US) | 2012-11-21 | — | — | EP | claimed |
| EP-2155162-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | Bausch & Lomb Incorporated (US) | 2010-02-24 | — | — | EP | claimed |
| WO-2008137496-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB INCORPORATED (US) | 2008-11-13 | — | — | WO | claimed |
| US-20080275000-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | SALIX PHARMACEUTICALS, INC. | 2008-11-06 | — | — | US | claimed |
| US-4427762-A | DEVELOPMENT WITH ALKALINE DEVELOPER MIXTURE | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-01-24 | — | — | US | claimed |
| EP-0089136-A2 | Oral hygiene products | THE PROCTER & GAMBLE COMPANY (US) | 1983-09-21 | — | — | EP | claimed |
| EP-0082015-A1 | Method of forming an image with a photographic cuprous halide material | KONICA CORPORATION (JP) | 1983-06-22 | — | — | EP | claimed |
| US-4285575-A | USING AN ELECTROCHROMIC ELECTROLYTE CONTAINING A CARBOXYLIC-CONTAINING COMPLEXING AGENT, A FERROUS SALT, A METAL SALT, AND A CHROMOGEN; DURABILITY | CANON KABUSHIKI KAISHA (JP) | 1981-08-25 | — | — | US | claimed |
| US-4212518-A | ELECTROCHROMIC CELL | CANON KABUSHIKI KAISHA (JP) | 1980-07-15 | — | — | US | claimed |
| US-20250136750-A1 | POLYESTER RESIN COMPOSITION FOR FILM CONTAINING TITANIUM-BASED CATALYST AND PREPARATION METHOD THEREFOR | TORAY ADVANCED MATERIALS KOREA INC. (KR) | 2025-05-01 | — | — | US | disclosed |
| US-20240132771-A1 | RE-CROSSLINKABLE HYPER-BRANCHED POLYMER GELS BASED ON A TRANSMIDATION REACTION | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2024-04-25 | — | — | US | disclosed |
| EP-4240804-A1 | RE-CROSSLINKABLE HYPER-BRANCHED POLYMER GELS BASED ON A TRANSMIDATION REACTION | The Curators Of The University Of Missouri (US) | 2023-09-13 | — | — | EP | disclosed |
| EP-0082015-A1 | Method of forming an image with a photographic cuprous halide material | KONICA CORPORATION (JP) | 1983-06-22 | — | — | EP | disclosed |
| US-4334046-A | POLYMERIZED IN THE PRESENCE OF AN IRON SALT AND CITRIC ACID | BAYER AKTIENGESELLSCHAFT (DE) | 1982-06-08 | — | — | US | disclosed |
| US-4285575-A | USING AN ELECTROCHROMIC ELECTROLYTE CONTAINING A CARBOXYLIC-CONTAINING COMPLEXING AGENT, A FERROUS SALT, A METAL SALT, AND A CHROMOGEN; DURABILITY | CANON KABUSHIKI KAISHA (JP) | 1981-08-25 | — | — | US | disclosed |
| US-3935862-A | Inhibition of conditions arising from microbial production of ammonia | PERSONAL PRODUCTS COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275000-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | PDE6D, PDE6H, CA2 | BLM 910/4885PMP22 4428/4885HSD17B10 3396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.